Skip to main content

AbbVie vs Alibaba: Founders, CEOs and History

AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Alibaba was founded in 1999 by Jack Ma (Ma Yun), Joe Tsai (Tsai Chung-hsin) and is led by Eddie Wu.

Company facts

AbbVie

Founded
2013
Headquarters
North Chicago, Illinois
Current CEO
Robert A. Michael
Employees
57,000

Alibaba

Founded
1999
Headquarters
Hangzhou, China
Current CEO
Eddie Wu
Employees
131,462

Founders

AbbVie

  • Abbott Laboratories (spin-off origin)

    Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.

AbbVie founders in full

Alibaba

  • Jack Ma (Ma Yun)

    Jack Ma (born Ma Yun on September 10, 1964) founded Alibaba in 1999, embarking on a journey that would reshape the modern Chinese economy.

  • Joe Tsai (Tsai Chung-hsin)

    Joe Tsai served as Alibaba's Executive Vice Chairman from 2013 until 2023 and became Non-Executive Chairman following the retirement of Jack Ma. In September 2023 he was elevated to Chairman of the Board.

Alibaba founders in full

CEOs and their tenures

AbbVie

  1. Richard A. Gonzalez2013–2024

    Founding Chairman and Chief Executive Officer

    Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.

    Source
  2. Robert A. Michael2024–present

    Chairman and Chief Executive Officer

    Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.

    Source
AbbVie CEO history in full

Alibaba

  1. Daniel Zhang (Zhang Yong)2015–2023

    Former CEO and Chairman, Alibaba Group

    Daniel Zhang served as Alibaba's CEO from 2015 to 2023, overseeing the company's growth from a primarily domestic e-commerce platform into a diversified technology conglomerate with global ambitions.

    Source
  2. Eddie Wu (Wu Yongming)2023–present

    Chief Executive Officer, Alibaba Group

    Eddie Wu was appointed CEO of Alibaba Group in September 2023, succeeding Daniel Zhang who had led the company since 2015.

    Source
Alibaba CEO history in full

Timeline: AbbVie and Alibaba side by side

  1. 1999Alibaba

    Alibaba.com Launched

    Jack Ma and 17 co-founders launch Alibaba.com from a Hangzhou apartment with $60,000 in pooled savings, creating a B2B online marketplace connecting Chinese manufacturers with international buyers.

  2. 1999Alibaba

    First Major Investment from SoftBank

    Masayoshi Son invests $20 million in Alibaba in a meeting reportedly lasting five minutes, alongside $5 million from Goldman Sachs, providing survival capital through the imminent dot-com crash.

  3. 2001Alibaba

    Gold Supplier Program Launch

    Alibaba launches the Gold Supplier verified membership program at $3,000 per year, generating approximately $10 million in first-year revenue and proving the B2B marketplace model's commercial viability.

  4. 2003Alibaba

    Taobao Launches to Challenge eBay

    Alibaba secretly develops and launches Taobao, a consumer-to-consumer marketplace offered free to both buyers and sellers, directly targeting eBay's Chinese market position. Within three years, Taobao surpasses eBay's Chinese market share.

  5. 2004Alibaba

    Alipay Escrow Service Created

    Alibaba creates Alipay as a payment escrow solution for Taobao transactions, holding buyer funds until delivery confirmation before releasing payment to sellers solving the trust barrier that was limiting online commerce adoption.

  6. 2008Alibaba

    Tmall (Taobao Mall) Launch

    Alibaba launches a premium B2C marketplace initially called Taobao Mall (later rebranded Tmall), allowing established brands to operate official storefronts with higher trust credentials and enabling Alibaba to serve the premium consumer segment.

  7. 2009Alibaba

    Alibaba Cloud Founded

    Alibaba launches Alibaba Cloud (Aliyun) as a cloud computing business, a decade ahead of many enterprise adoption cycles, positioning it to become Asia Pacific's dominant cloud provider.

  8. 2011Alibaba

    First Singles' Day Shopping Festival

    Alibaba transforms the informal 'Singles' Day' celebration on November 11 into a promotional shopping event on Taobao and Tmall, generating ~$130 million (936 million yuan) in sales a figure that would grow more than 100-fold in subsequent years.

  9. 2013AbbVie

    AbbVie Launches as an Independent Company

    AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.

  10. 2014Alibaba

    Record-Breaking NYSE IPO

    Alibaba completes its initial public offering on the New York Stock Exchange on September 19, 2014, raising $25 billion the largest IPO in US stock market history at that time at a valuation of approximately $168 billion.

  11. 2015AbbVie

    Pharmacyclics Acquisition Completed

    AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.

  12. 2019AbbVie

    Skyrizi Receives Initial U.S. Approval

    The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.

  13. 2019AbbVie

    Rinvoq Receives Initial U.S. Approval

    The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.

  14. 2019Alibaba

    Dual Listing on Hong Kong Stock Exchange

    Alibaba completes a secondary listing on the Hong Kong Stock Exchange, raising an additional $13 billion and broadening its investor base among Asian institutional and retail investors, reducing dependence on US capital markets.

  15. 2020AbbVie

    Allergan Acquisition Completed

    AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.

  16. 2021Alibaba

    Record Antitrust Fine

    Chinese regulators impose a 18.23 billion yuan ($2.8 billion USD) antitrust fine on Alibaba following a months-long investigation into its 'choose one from two' exclusivity practices at the time, the largest antitrust fine in Chinese regulatory history.

  17. 2023AbbVie

    U.S. Humira Biosimilar Competition Begins

    Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.

  18. 2023Alibaba

    Six-Business-Unit Restructuring Announced

    Alibaba announces its most significant organizational restructuring, dividing the company into six independent business units each with its own CEO and board: Taobao Tmall Group, Cloud Intelligence Group, Alibaba International Digital Commerce Group, Cainiao S…

  19. 2024AbbVie

    ImmunoGen Acquisition Completed

    AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.

  20. 2024AbbVie

    Robert A. Michael Becomes CEO

    Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.

  21. 2024AbbVie

    Cerevel Therapeutics Acquisition Completed

    AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.

  22. 2025AbbVie

    Robert A. Michael Becomes Chairman

    Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.

  23. 2025AbbVie

    FY2025 Revenue Reaches $61.160 Billion

    AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.

  24. 2026AbbVie

    Q1 2026 Revenue Reaches $15.002 Billion

    AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.

Acquisitions

AbbVie

  • ImmunoGen, Inc.2024$10.1B
  • Cerevel Therapeutics2024$8.7B
  • Allergan plc2020$63B
  • Pharmacyclics, Inc.2015$21B
All AbbVie acquisitions

Alibaba

  • Sun Art Retail Group (Auchan Retail China)2020$3.6B
  • Ele.me2018$9.5B
  • Trendyol (stake investment)2018$750M
  • Lazada2016$1B
  • Youku Tudou2016$3.7B
All Alibaba acquisitions

Questions about AbbVie vs Alibaba

Who is the CEO of AbbVie Inc. and Alibaba Group Holding Limited?

AbbVie Inc. is led by Robert A. Michael and Alibaba Group Holding Limited is led by Eddie Wu. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.

When was AbbVie Inc. founded vs Alibaba Group Holding Limited?

Alibaba Group Holding Limited was founded in 1999 — 14 years before AbbVie Inc., which was founded in 2013. Alibaba Group Holding Limited's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..

How many employees does AbbVie Inc. have compared to Alibaba Group Holding Limited?

AbbVie Inc. employs approximately 57,000 people, while Alibaba Group Holding Limited employs approximately 131,462. Alibaba Group Holding Limited has the larger workforce at 131,462 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).

Where are AbbVie Inc. and Alibaba Group Holding Limited headquartered?

AbbVie Inc. is headquartered in United States and Alibaba Group Holding Limited is headquartered in China. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.

Who founded AbbVie Inc. and Alibaba Group Holding Limited?

AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Alibaba Group Holding Limited was founded by Jack Ma (Ma Yun), Joe Tsai (Tsai Chung-hsin).

Which company has a longer operating history — AbbVie Inc. or Alibaba Group Holding Limited?

Alibaba Group Holding Limited has been operating for approximately 27 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.

Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Alibaba overview

Content is for informational purposes only. Not financial advice. Data sourced from SEC filings, annual reports, and public records. See our full disclaimer and methodology.